诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVAX 诺瓦瓦克斯医药

已收盘 07-26 16:00:00 EDT

17.11

+0.44

+2.64%

盘后17.07

-0.04-0.23%

19:59 EDT

最高17.81	最低16.82	成交量714.38万
今开17.04	昨收16.67	日振幅5.94%
总市值24.03亿	流通市值20.96亿	总股本1.40亿
成交额1.23亿	换手率5.83%	流通股本1.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"诺瓦瓦克斯医药","latestPrice":17.11,"timestamp":1722024000000,"preClose":16.67,"halted":0,"volume":7143752,"hourTrading":{"tag":"盘后","latestPrice":17.07,"preClose":17.11,"latestTime":"19:59 EDT","volume":83389,"amount":1425928.5126,"timestamp":1722038371222},"delay":0,"floatShares":122476644,"shares":140417976,"eps":-3.491075,"marketStatus":"已收盘","marketStatusCode":5,"change":0.44,"latestTime":"07-26 16:00:00 EDT","open":17.04,"high":17.81,"low":16.82,"amount":122981912.386872,"amplitude":0.059388,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.491075,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"adjPreClose":16.67,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":17.03,"preClose":16.67,"latestTime":"09:29 EDT","volume":96694,"amount":1660111.7282099999,"timestamp":1722000569053},"postHourTrading":{"tag":"盘后","latestPrice":17.07,"preClose":17.11,"latestTime":"19:59 EDT","volume":83389,"amount":1425928.5126,"timestamp":1722038371222},"volumeRatio":0.982233,"impliedVol":1.3406,"impliedVolPercentile":0.6587},"requestUrl":"/m/hq/s/NVAX","defaultTab":"news","newsList":[{"id":"1141285770","title":"异动解读 | 诺瓦瓦克斯医药股价大涨5.2% 疫苗业务前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1141285770","media":"异动解读","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/1141285770?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:38","pubTimestamp":1722001125,"startTime":"0","endTime":"0","summary":"2024年7月26日,诺瓦瓦克斯医药(NVAX)股价盘中大涨5.2%,引发市场关注。据报道,该公司是一家专注于开发疫苗的生物技术公司,主要从事预防多种疾病的新型疫苗研发。\n\n尽管公开报道未透露股价大涨的直接原因,但分析人士认为,市场对该公司疫苗业务前景的看好或是主要推手。作为一家处于临床开发阶段的疫苗公司,诺瓦瓦克斯医药的疫苗技术有望广泛应用于各种人类传染病领域,市场潜力巨大。\n\n此外,公司最新财报显示营收同比大幅增长,盈利能力持续改善,基本面向好或也为股价上涨增添了动力。不过,由于缺乏直接利好消息支撑,股价能否持续上涨仍有待观察。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX"],"gpt_icon":0},{"id":"2454347143","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454347143","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454347143?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:31","pubTimestamp":1722000694,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时31分，诺瓦瓦克斯医药股票出现波动，股价大幅上涨5.28%。截至发稿，该股报17.55美元/股，成交量40.7978万股，换手率0.28%，振幅1.80%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为0.05%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。该公司认为，其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213135af9458fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213135af9458fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4588","BK4547","BK4585","BK4139","NVAX"],"gpt_icon":1},{"id":"2454187260","title":"诺瓦瓦克斯医药盘中异动 急速上涨5.00%报16.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454187260","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454187260?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:19","pubTimestamp":1721917166,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时19分，诺瓦瓦克斯医药股票出现波动，股价快速上涨5.00%。截至发稿，该股报16.17美元/股，成交量168.724万股，换手率1.15%，振幅4.94%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.89%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407252219269682054c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407252219269682054c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","NVAX","BK4139","BK4568","BK4547"],"gpt_icon":1},{"id":"2454318418","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.00%报15.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454318418","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454318418?lang=zh_cn&edition=full","pubTime":"2024-07-25 02:27","pubTimestamp":1721845620,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日02时27分，诺瓦瓦克斯医药股票出现波动，股价急速下挫5.00%。截至发稿，该股报15.57美元/股，成交量502.396万股，换手率3.41%，振幅6.28%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.33%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725022700941fa34d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725022700941fa34d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","NVAX","BK4568","BK4585","BK4139","BK4547"],"gpt_icon":1},{"id":"2453071557","title":"诺瓦瓦克斯医药(NVAX)盘前挫3.54% 杰富瑞削其目标价18.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453071557","media":"金吾财讯","labels":["rating"],"top":-1,"share":"https://www.laohu8.com/m/news/2453071557?lang=zh_cn&edition=full","pubTime":"2024-07-24 17:59","pubTimestamp":1721815199,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前股价走低，暂跌3.54%，报15.81美元。消息面上，杰富瑞将其目标价从38美元下调至31美元，维持“买入”评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/ZjE4MDdhNTRkYTVhY2QzODgyOWQwYzcxZDQ3NTA3Njg3NjgwMzk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZjE4MDdhNTRkYTVhY2QzODgyOWQwYzcxZDQ3NTA3Njg3NjgwMzk=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"278145","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX"],"gpt_icon":1},{"id":"2453606616","title":"诺瓦瓦克斯医药盘中异动 下午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453606616","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453606616?lang=zh_cn&edition=full","pubTime":"2024-07-24 02:02","pubTimestamp":1721757754,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日02时02分，诺瓦瓦克斯医药股票出现波动，股价急速拉升5.02%。截至发稿，该股报15.69美元/股，成交量281.911万股，换手率1.91%，振幅6.83%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.49%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724020234af93b0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724020234af93b0a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4585","BK4547","NVAX","BK4588"],"gpt_icon":1},{"id":"1116467814","title":"异动解读 | 分析师看好诺瓦瓦克斯医药长期前景 股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116467814","media":"异动解读","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/1116467814?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:08","pubTimestamp":1721668098,"startTime":"0","endTime":"0","summary":"7月22日,诺瓦瓦克斯医药股价在盘中大涨5.27%,引发市场关注。据悉,这与投资银行杰富瑞对该公司的最新评级和目标价调整有关。诺瓦瓦克斯医药是一家专注于开发和商业化新型疫苗的生物技术公司。其核心产品包括新冠疫苗Nuvaxovid和流感疫苗NanoFlu等。虽然近期新冠疫苗需求下滑对公司业绩造成一定压力,但分析师预计随着疫情形势好转,公司的疫苗产品线将重拾增长动力。同时,公司在研管线中的其他候选疫苗也有望为未来业绩增长注入新动能。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX"],"gpt_icon":0},{"id":"2453713788","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.02%报14.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453713788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453713788?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:04","pubTimestamp":1721667892,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日01时04分，诺瓦瓦克斯医药股票出现波动，股价急速拉升5.02%。截至发稿，该股报14.55美元/股，成交量271.022万股，换手率1.84%，振幅4.04%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.36%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723010452af9375cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723010452af9375cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","NVAX","BK4139","BK4547","BK4585","BK4588"],"gpt_icon":1},{"id":"2453790496","title":"官宣：终止合作！","url":"https://stock-news.laohu8.com/highlight/detail?id=2453790496","media":"中国基金报","labels":["Company Corporation"],"top":-1,"share":"https://www.laohu8.com/m/news/2453790496?lang=zh_cn&edition=full","pubTime":"2024-07-23 00:12","pubTimestamp":1721664720,"startTime":"0","endTime":"0","summary":"已收到1.74亿元里程碑款7月22日，万泰生物宣布其全资子公司万泰沧海与葛兰素史克签署了合作协议终止函，决定不再继续新一代宫颈癌疫苗的开发和商业化合作。对于此次合作的终止，万泰生物表示，双方将真诚合作，在100日内按照《合作协议》约定，妥善处理终止事宜。尽管合作终止，但万泰沧海仍将协助葛兰素史克完成与协议终止前相关的临床试验、药物警戒以及质量方面工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656113114&idx=4&sn=c8e8ebfcdbbaa169bdf89930e5238633&chksm=8a5f82432d31afade341b719e58e2e3c87e4b32ba52115f1a49b2cc88ca27173833c514c5101&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656113114&idx=4&sn=c8e8ebfcdbbaa169bdf89930e5238633&chksm=8a5f82432d31afade341b719e58e2e3c87e4b32ba52115f1a49b2cc88ca27173833c514c5101&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1981816686.USD","BK1200","BIDU","BK1589","NVAX"],"gpt_icon":1},{"id":"2453380751","title":"净利预计下降超8成，万泰生物正陷入HPV疫苗“围城 ”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2453380751","media":"蓝鲸财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453380751?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:11","pubTimestamp":1721639473,"startTime":"0","endTime":"0","summary":"但在下跌的公司中，万泰生物是里面较受瞩目的一家。回眸万泰生物的发家史，公司成立于1991年，主要从事生物诊断试剂与疫苗的研发及生产，核心产品是2019年上市的二价HPV疫苗“馨可宁” ，其不仅是国内首个宫颈癌疫苗，同时也打破了国际大厂对中国HPV疫苗市场的绝对垄断。但如今却情况急转直下，从2023年开始，万泰生物二价HPV疫苗销售收入出现下降，去年年报时归母净利润下降了大约74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/235583","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1589","NVAX","BK1200","LU1981816686.USD"],"gpt_icon":1},{"id":"2453759994","title":"杰富瑞下调诺瓦瓦克斯医药目标价至31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453759994","media":"新浪财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453759994?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:03","pubTimestamp":1721639034,"startTime":"0","endTime":"0","summary":"格隆汇7月22日｜杰富瑞：将诺瓦瓦克斯医药的目标价从38美元下调至31美元，维持“买入”评级。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-07-22/doc-inceyxrw2122179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["NVAX"],"gpt_icon":0},{"id":"2452471571","title":"诺瓦瓦克斯医药盘中异动 早盘大幅下挫5.08%报14.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452471571","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452471571?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:39","pubTimestamp":1721396355,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时39分，诺瓦瓦克斯医药股票出现异动，股价急速跳水5.08%。截至发稿，该股报14.20美元/股，成交量50.7877万股，换手率0.34%，振幅4.68%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.72%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719213915aefa8a09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719213915aefa8a09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BK4585","NVAX","BK4568","BK4588"],"gpt_icon":1},{"id":"2452480329","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452480329","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452480329?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:03","pubTimestamp":1721311413,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时03分，诺瓦瓦克斯医药股票出现异动，股价快速拉升5.00%。截至发稿，该股报16.64美元/股，成交量123.364万股，换手率0.84%，振幅6.50%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.20%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220333aefa57f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220333aefa57f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","NVAX","SILO","BK4585","BK4547","BK4568"],"gpt_icon":1},{"id":"2452165488","title":"诺瓦瓦克斯医药盘中异动 早盘急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165488","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452165488?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:40","pubTimestamp":1721227251,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时40分，诺瓦瓦克斯医药股票出现波动，股价大幅跳水5.05%。截至发稿，该股报15.61美元/股，成交量358.24万股，换手率2.43%，振幅5.41%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为1.89%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717224052af92cc43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717224052af92cc43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","NVAX","BK4139","BK4588","BK4568","BK4547"],"gpt_icon":1},{"id":"2451621913","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451621913","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451621913?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:11","pubTimestamp":1721139102,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时11分，诺瓦瓦克斯医药股票出现波动，股价快速拉升5.03%。截至发稿，该股报15.88美元/股，成交量287.38万股，换手率1.95%，振幅7.54%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.41%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162211429681d355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162211429681d355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4547","BK4585","BK4588","NVAX"],"gpt_icon":1},{"id":"2451624220","title":"诺瓦瓦克斯医药盘中异动 临近午盘股价大涨5.10%报13.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451624220","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451624220?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:31","pubTimestamp":1721057464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时31分，诺瓦瓦克斯医药股票出现异动，股价快速上涨5.10%。截至发稿，该股报13.78美元/股，成交量311.817万股，换手率2.12%，振幅3.81%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.16%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。该公司认为，其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715233104aef9c2fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715233104aef9c2fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4547","BK4585","BK4588","BK4139","NVAX"],"gpt_icon":0},{"id":"2450367535","title":"抗疫概念股普遍扬升 诺瓦瓦克斯医药(NVAX)涨逾4% 美国疾控中心建议年龄满6个月及以上人群接种疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2450367535","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450367535?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:57","pubTimestamp":1720792643,"startTime":"0","endTime":"0","summary":"金吾财讯 | 抗疫概念股普遍扬升，诺瓦瓦克斯医药(NVAX)涨4.32%，Moderna(MRNA)涨3.41%，BioNTech(BNTX)涨2.20%，阿斯利康(AZN)涨1.92%，美疾病预防控制中心关于COVID-19的最新数据显示，截至6月底，44个州的感染人数正在增加或可能增加。美国疾病控制与预防中心建议年龄六个月及以上的人接种更新的COVID-19疫苗。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277731","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NVAX","BK4585","159646","MRNA","BK4532","BK4547","BK4551","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4568","BK4548","BK4534","LU1829250122.USD","BK4533","LU2236285917.USD","BK4501","BK4535","BK4588","BK4139","BNTX","AZN"],"gpt_icon":0},{"id":"2450535979","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨5.00%报13.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535979","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450535979?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:40","pubTimestamp":1720791631,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时40分，诺瓦瓦克斯医药股票出现波动，股价大幅上涨5.00%。截至发稿，该股报13.61美元/股，成交量81.6321万股，换手率0.55%，振幅2.78%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.76%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214031af921d18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214031af921d18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4588","BK4547","NVAX","BK4585"],"gpt_icon":0},{"id":"2450247304","title":"诺瓦瓦克斯医药(NVAX)盘前升近4% 已向美国和加拿大申请新冠疫苗更新版本","url":"https://stock-news.laohu8.com/highlight/detail?id=2450247304","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450247304?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:50","pubTimestamp":1720777827,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前股价抬升，暂涨3.78%，报13.45美元。公司于本周二表示，已向加拿大卫生部提交了申请，申请授权其2024-2025年期Covid-19生物-疫苗用于12岁及以上人群，该更新版本的疫苗针对JN.1、KP.2、KP.3及其他JN.1亚系病毒株。此前媒体报道，诺瓦瓦克斯医药-新冠疫苗的更新版本目前正在接受美国FDA审查，用于预防12岁及以上个体的新冠病毒感染。美疾病预防控制中心关于COVID-19的最新数据显示，截至6月底，44个州的感染人数正在增加或可能增加。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277706","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","159646","BK4588","BK4568","BK4585","NVAX","BK4547"],"gpt_icon":0},{"id":"2450365948","title":"诺瓦瓦克斯医药盘中异动 大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450365948","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450365948?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:55","pubTimestamp":1720706113,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时55分，诺瓦瓦克斯医药股票出现波动，股价快速上涨5.11%。截至发稿，该股报12.55美元/股，成交量105.662万股，换手率0.72%，振幅4.06%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.40%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711215514af91de7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711215514af91de7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4568","NVAX","BK4547","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":0.1143},{"period":"1month","weight":0.1907},{"period":"3month","weight":3.0758},{"period":"6month","weight":3.1059},{"period":"1year","weight":1.028},{"period":"ytd","weight":2.4729}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novavax, Inc.是一家新型临床阶段生物制药公司，致力于发现、开发和商业化纳米颗粒重组疫苗和佐剂。公司的疫苗技术平台是根据专有纳米疫苗重组技术开发的，包括病毒样颗粒和蛋白质纳米颗粒候选疫苗。公司的候选疫苗是转基因的三维纳米结构，结合了免疫重要蛋白。公司的疫苗产品针对各种传染病，还有目前在临床开发的针对呼吸道合胞体病毒(RSV)、季节性流感和大流行性流感的产品。此外，CPL生物制剂私人有限公司(CPLB)，其合资公司在印度，正积极开发一系列疫苗候选产品，是由诺瓦瓦克斯公司转基因完成的。1987年，诺瓦瓦克斯公司在特拉华州的法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.655172,"avgChangeRate":0.101878},{"month":2,"riseRate":0.586207,"avgChangeRate":0.042134},{"month":3,"riseRate":0.275862,"avgChangeRate":-0.034367},{"month":4,"riseRate":0.448276,"avgChangeRate":0.007943},{"month":5,"riseRate":0.517241,"avgChangeRate":0.126888},{"month":6,"riseRate":0.517241,"avgChangeRate":0.09837},{"month":7,"riseRate":0.551724,"avgChangeRate":0.02869},{"month":8,"riseRate":0.535714,"avgChangeRate":0.039529},{"month":9,"riseRate":0.464286,"avgChangeRate":-0.045486},{"month":10,"riseRate":0.321429,"avgChangeRate":0.038967},{"month":11,"riseRate":0.357143,"avgChangeRate":0.005457},{"month":12,"riseRate":0.392857,"avgChangeRate":-0.03691}],"exchange":"NASDAQ","name":"诺瓦瓦克斯医药","nameEN":"Novavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺瓦瓦克斯医药,NVAX,诺瓦瓦克斯医药股票,诺瓦瓦克斯医药股票老虎,诺瓦瓦克斯医药股票老虎国际,诺瓦瓦克斯医药行情,诺瓦瓦克斯医药股票行情,诺瓦瓦克斯医药股价,诺瓦瓦克斯医药股市,诺瓦瓦克斯医药股票价格,诺瓦瓦克斯医药股票交易,诺瓦瓦克斯医药股票购买,诺瓦瓦克斯医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}